FCX Research and Development Laboratory
Pentapharm has a long-standing tradition as an innovative and reliable supplier of active ingredients for the pharmaceutical, diagnostic and cosmetic industry. Our roots as researchers, developers and manufacturers of state-of-the-art cosmetic products reach back to 1948. Pentapharm’s strong corporate identity encompasses sophisticated tools in research and development.
FCX President and CEO
Sandra Harshman graduated with a B.A. in Accounting from Alameda State. Ms. Harshman served as a tax accountant and worked for firms like Touche Ross & Co. Sandra also worked as a comptroller for Mountain States Health Corporation, the Pepsi Cola Corporation supervising the quality of accounting and financial reporting of the organization as well as chaired The Idaho Accountants Association and established the first leads group in the State of Idaho. She established Charge 2 Card Corporation in 1995, an MSP (merchant service provider) business that offered retail business credit card processing services, as well as loyalty, prepaid gift card programs and Visa- Mastercard Card issuance to banks. Ms. Harshman was awarded the National Business Women of the Year award in 2003 and received the award in Washington D. C. She has also authored two books one off which is called . . .Done! a tutorial book on setting up a business and achieving success.
Dr. Mario S. Kambouris Ph.D., FACMG
FCX Molecular and Medical Genetics Director
Dr. Kambouris received his Ph.D. in Medical and Molecular Genetics from Indiana University School of Medicine. Following his Ph.D, he did his Post-Doctoral Fellowship at Henry Ford Hospital in Detroit, MI at the Medical Genetics & Birth Defect Center. Dr. Kambouris is certified by the American Board of Medical Genetics in two Genetics disciplines: Clinical Molecular Genetics and PhD Medical Genetics. Dr. Kambouris has served as an assistant professor of Genetics at Yale University of Medicine in the Department of Genetics, and serves as the FCX scientist for Predictive Genomics DNA Profiling.
Scott Wardle is a 24 year United States Air Force veteran and military aviator. He obtained his BS from the United States Air Force Academy and obtained his Masters from Webster’s University. Over his career Mr.Wardle has oversaw the operation of varies size military units. From 2007-2010 he had the responsibility of managing the daily operations of 77 aircraft worth 2.5 billion dollars through the Pacific Rim region. Mr. Wardle led an operational command unit that received “Best in the USAF” for two consecutive years. Mr. Wardle has served as the senior USAF airlift advisor to the executive Task Force leadership during the Burma Typhoon in 2008. Mr. Wardle also was selected as the senior USAF liaison to the senior military executives during the 2011 Japan disaster relief efforts and was the lead Air Force representative in the evacuation of 7,500 Department of Defense dependents from the Honshu, the main Japanese island. Mr.Wardle is currently the Chief of Operations and Strategic Plans for a 650 personnel contingency response force that can be deployed around the globe within 24 hours of notification.